Announcements Trials
Browse Landscape

Phase

Phase 2 9Phase 3 2Phase 1/2 2Phase 4 1Phase 2/3 1

Status

Unknown 1Enrolling by invitation 1

Sponsor Class

OTHER 294INDUSTRY 250NETWORK 103NIH 67OTHER_GOV 10UNKNOWN 2

Study Type

Interventional 2

Sponsor

Cancer Type

Thoracic 1Head & Neck 1

Conditions

Nasopharyngeal Carcinoma 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Paclitaxel 6Radiotherapy 3Epirubicin 3Radiation Dose Hypofractionation 2Radiation 2Docetaxel 2Cyclophosphamide 2Cisplatin 2Carboplatin 2Capecitabine 2pegylated granulocyte colony-stimulating factor 1nabiximols 1aumolertinib 1Zoledronic Acid 1Vinorelbine 1Temozolomide 1TP protocol 1Standard of Care 1S 1 (combination) 1Radiotherapy, Intensity-Modulated 1Platinum 1Pemetrexed 1Neoadjuvant Therapy 1Irinotecan 1Granulocyte Colony-Stimulating Factor 1Decitabine 1Chemotherapy, Adjuvant 1Cetuximab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 3 × UNKNOWN × Cisplatin × Clear all
NCT04762459 2022-02-24

APEX

ChineseAMS

Phase 3 Enrolling by invitation
606 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT01817023 2021-01-29

The Role of Concurrent Chemotherapy for Lower Risk Locally Advanced Nasopharyngeal Carcinoma(NPC) in the Era of IMRT

ChineseAMS

Phase 3 Unknown
590 enrolled
Head & Neck

Nasopharyngeal Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡